Sam Campbell

Sam Campbell is CritiTech’s Chairman, providing guidance to the management team. He assists with long-term strategic development and helps with special projects. Sam has over 30 years of experience with executive leadership and investment management with early-stage life science companies.

Prior to joining CritiTech in 2003, Sam held roles as the President of Campbell-Becker, and early stage investor for several life science companies, as well as Developer of the Lawrence Life Sciences Center, part of the largest university-based incubator in the midwest. He currently serves on the Boards of NanOlogy, LLC, an oncology drug development company, and the University National Bank.

Sam holds an M.B.A. and a B.A. in Business & History from the University of Kansas. He is a lifelong cattle and horse rancher, enjoys working with livestock and spending time with family.